No difference in survival with immediate vs. delayed coronary angiography after cardiac arrest in NSTEMI patients

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

$Clinical benefit with SGLT inhibitor in diabetes patients with HF independent of ejection fraction$ $Clinical benefit with SGLT inhibitor in diabetes patients with HF independent of ejection fraction$
Clinical benefit with SGLT2 inhibitor in diabetes patients with HF independent of ejection fraction
Clinical benefit with SGLT2 inhibitor in diabetes patients with HF independent of ejection fraction
ACC.19
Clinical benefit with SGLT2 inhibitor in diabetes patients with HF independent of ejection fraction
- Dr. Eri Kato
Detection of AF with wearable technology to prevent stroke
Detection of AF with wearable technology to prevent stroke
ACC.19
Detection of AF with wearable technology to prevent stroke
Benefits of early initiation of ARNI in acute HF confirmed in open-label extension study
Benefits of early initiation of ARNI in acute HF confirmed in open-label extension study
ACC.19
Benefits of early initiation of ARNI in acute HF confirmed in open-label extension study
- Adam DeVore, MD
Cholesterol synthesis inhibitor has potential to be add-on therapy to statin in patients with high CV risk
Cholesterol synthesis inhibitor has potential to be add-on therapy to statin in patients with high CV risk
ACC.19
Cholesterol synthesis inhibitor has potential to be add-on therapy to statin in patients with high CV risk
- Anne Carol Goldberg, MD